MFDS
- Status: likely_approved
🇰🇷 Cerebyx in South Korea
Cerebyx (FOSPHENYTOIN) regulatory status in South Korea.
Marketing authorisation
Cerebyx in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Cerebyx approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Cerebyx in South Korea?
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.